The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the media headlines. However, selecting the biotechnology firms for investment requires not only an understanding of the company's finances, but also deep knowledge of the company's potential and the potential and scientific validity of it's products and technologies. Our Mission is evaluating biotechnology companies, their products, their technologies, scientists, managements, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a heightened understanding and appreciation for the biotechnology industry. The Prohost Letter has been in circulation since 1992. Our readers are comprised of venture capital, fund managers, investors, medical professionals and individuals with one common interest, biotechnology. Prohost Letter is posted in the members areas on the www.prohostbiotech.com. around 40 times a year. Articles are posted several times a week for subscribers in TODAY'S HIGHLIGHTS section and in News & Comments sector for all website visitors
I am individual investor that has been investing for his retirement for the past 40 years. During that time I have had great successes and great losses but with each win and loss I have learned something about the market and the stock I own. I do not invest for a living as my real job is as a full time Plant Manager at a local manufacturing company that makes consumer products that ship worldwide. Investing is a serious hobby for me and I spend a lot of free time doing it. I know that my wife of 34 years would say that I spend to much time at it but we will both have the opportunity to appreciate my efforts in the years ahead.